194 related articles for article (PubMed ID: 28240050)
1. LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.
Yong BC; Lu JC; Xie XB; Su Q; Tan PX; Tang QL; Wang J; Huang G; Han J; Xu HW; Shen JN
Tumour Biol; 2017 Feb; 39(2):1010428317691188. PubMed ID: 28240050
[TBL] [Abstract][Full Text] [Related]
2. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
3. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
4. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
Jiang J; Li Y; Jiang Z
Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor associates with survival and regulates tumour progression in osteosarcoma.
Tieken C; Verboom MC; Ruf W; Gelderblom H; Bovée JV; Reitsma PH; Cleton-Jansen AM; Versteeg HH
Thromb Haemost; 2016 May; 115(5):1025-33. PubMed ID: 26763081
[TBL] [Abstract][Full Text] [Related]
7. LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients.
Wanka G; Schmoeckel E; Mayr D; Fuerst S; Kuhn C; Mahner S; Knabl J; Karsten MM; Dannecker C; Heidegger HH; Vattai A; Jeschke U; Jueckstock J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291445
[TBL] [Abstract][Full Text] [Related]
8. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
9. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.
Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S
Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412
[TBL] [Abstract][Full Text] [Related]
10. p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.
Li Y; Nakka M; Kelly AJ; Lau CC; Krailo M; Barkauskas DA; Hicks JM; Man TK
Cancer Res; 2016 Jul; 76(13):4002-11. PubMed ID: 27197201
[TBL] [Abstract][Full Text] [Related]
11. CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome.
Gvozdenovic A; Arlt MJ; Campanile C; Brennecke P; Husmann K; Li Y; Born W; Muff R; Fuchs B
J Bone Miner Res; 2013 Apr; 28(4):838-47. PubMed ID: 23169460
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion.
Nagao-Kitamoto H; Setoguchi T; Kitamoto S; Nakamura S; Tsuru A; Nagata M; Nagano S; Ishidou Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S
Cancer Lett; 2015 Jan; 356(2 Pt B):855-61. PubMed ID: 25449781
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma.
Ji T; Guo Y; Kim K; McQueen P; Ghaffar S; Christ A; Lin C; Eskander R; Zi X; Hoang BH
Mol Cancer; 2015 Apr; 14():86. PubMed ID: 25890345
[TBL] [Abstract][Full Text] [Related]
17. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway.
Li L; Liang S; Wasylishen AR; Zhang Y; Yang X; Zhou B; Shan L; Han X; Mu T; Wang G; Xiong S
Oncotarget; 2016 Apr; 7(14):18021-35. PubMed ID: 26933804
[TBL] [Abstract][Full Text] [Related]
18. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma.
Liu JF; Tsao YT; Hou CH
Oncotarget; 2015 Dec; 6(38):40880-95. PubMed ID: 26503469
[TBL] [Abstract][Full Text] [Related]
19. CEP55 promotes the proliferation and invasion of tumour cells via the AKT signalling pathway in osteosarcoma.
Xu L; Xia C; Sheng F; Sun Q; Xiong J; Wang S
Carcinogenesis; 2018 Apr; 39(4):623-631. PubMed ID: 29579156
[TBL] [Abstract][Full Text] [Related]
20. RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling.
Li Y; Liu M; Yang S; Fuller AM; Karin Eisinger-Mathason TS; Yang S
Oncogene; 2021 Apr; 40(14):2553-2566. PubMed ID: 33686240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
